A clinical trial involving nesiritide has been updated to completed status as of November 13, 2026. The study, registered as NCT05434286, is titled "Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury." No phase was specified for this trial in the available record. The trial status listed on ClinicalTrials.gov now reads completed. No results, outcomes, or efficacy data were included in this update. Nesiritide remains classified as an unapproved research compound. This update reflects only a change in the trial's recorded status and does not indicate any findings, benefits, or risks associated with nesiritide. Readers should not interpret the completed status as confirmation of any particular result. For further context on nesiritide, including its research classification and background, see the compound overview.
Nesiritide Trial NCT05434286 Marked Completed as of Nov 13, 2026
See the full nesiritide overview
Source: https://clinicaltrials.gov/study/NCT05434286